SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001104659-22-107752
Filing Date
2022-10-11
Accepted
2022-10-11 16:32:16
Documents
13
Period of Report
2022-10-06
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K tm2227959d1_8k.htm   iXBRL 8-K 29437
2 EXHIBIT 10.2 tm2227959d1_ex10-2.htm EX-10.2 14895
  Complete submission text file 0001104659-22-107752.txt   221082

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA nnvc-20221006.xsd EX-101.SCH 3048
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE nnvc-20221006_lab.xml EX-101.LAB 34476
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE nnvc-20221006_pre.xml EX-101.PRE 22605
7 EXTRACTED XBRL INSTANCE DOCUMENT tm2227959d1_8k_htm.xml XML 3451
Mailing Address 1 CONTROLS DRIVE SHELTON CT 06484
Business Address 1 CONTROLS DRIVE SHELTON CT 06484 (203) 937-6137
NANOVIRICIDES, INC. (Filer) CIK: 0001379006 (see all company filings)

IRS No.: 760674577 | State of Incorp.: NV | Fiscal Year End: 0630
Type: 8-K | Act: 34 | File No.: 001-36081 | Film No.: 221304408
SIC: 2834 Pharmaceutical Preparations